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Abstract 
Background: The Coronavirus disease 2019 (COVID‑19) pandemic has underlined the urgent need for reliable, multi‑
center, and full‑admission intensive care data to advance our understanding of the course of the disease and investi‑
gate potential treatment strategies. In this study, we present the Dutch Data Warehouse (DDW), the first multicenter 
electronic health record (EHR) database with full‑admission data from critically ill COVID‑19 patients.
Methods: A nation‑wide data sharing collaboration was launched at the beginning of the pandemic in March 2020. 
All hospitals in the Netherlands were asked to participate and share pseudonymized EHR data from adult critically ill 
COVID‑19 patients. Data included patient demographics, clinical observations, administered medication, laboratory 
determinations, and data from vital sign monitors and life support devices. Data sharing agreements were signed with 
participating hospitals before any data transfers took place. Data were extracted from the local EHRs with prespeci‑
fied queries and combined into a staging dataset through an extract–transform–load (ETL) pipeline. In the consecu‑
tive processing pipeline, data were mapped to a common concept vocabulary and enriched with derived concepts. 
Data validation was a continuous process throughout the project. All participating hospitals have access to the DDW. 
Within legal and ethical boundaries, data are available to clinicians and researchers.
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Introduction
The Corona virus disease 2019 (COVID-19) pandemic 
has placed an unprecedented burden on intensive care 
units around the world. Many intensive care units still 
face high death rates, and the number of critically ill 
patients still exceeds available intensive care unit (ICU) 
beds in some areas [1]. More than ever before, COVID-
19 has shown the need for concerted research efforts 
among the intensive care community to understand the 
course of severe COVID-19 disease, to identify potential 
treatment strategies and to guide resource allocation.
Research with routinely collected electronic health 
record (EHR) data has increasingly gained interest in 
the ICU over the last decade [2]. There has been a wide-
spread transition toward EHR systems, enabling the rou-
tine capture of individual patient data throughout ICU 
admission [3]. Moreover, several individual hospitals 
have extracted these EHR data and converted them into 
critical care datasets available for research, including the 
Medical Information Mart for Intensive Care (MIMIC) 
[4], AmsterdamUMCdb [5], and HiRID [6]. These data-
sets have laid the groundwork for working with EHR data 
and have advanced medical data science in the field of 
critical care.
However, rather than single-center data alone, the 
COVID-19 pandemic has underlined the need for accu-
rate and verifiable multicenter data [7, 8]. The novelty of 
COVID-19 and absence of treatment guidelines resulted 
in practice variation between centers, emphasizing the 
limits of single-center research and the need for multi-
center research into effective treatment strategies [9]. 
Furthermore, medical transfers, different levels of care, 
and care practice differences between hospitals hamper 
the extrapolation of single-center data. Patient demo-
graphics, for example, have been shown to differ con-
siderably between centers [10]. Multicenter data are 
therefore crucial, but assembling data from multiple 
centers yields major challenges.
We initiated a large-scale data sharing collabora-
tion in the Netherlands that resulted in the Dutch Data 
Warehouse (DDW), a complete-admission and mul-
ticenter database with EHR data from critically ill 
COVID-19 patients. The DDW was designed with an 
interdisciplinary team of legal advisors, privacy officers, 
data engineers, IT-professionals, data scientists, statisti-
cians, and clinicians. This paper presents a full report on 
the first stable version of the database and addresses the 
major challenges in the construction of the DDW. Given 
the crisis, a brief overview of the preliminary dataset 
was published as a letter [11]. In the present report, we 
expand on the methodology underlying the DDW and 
show the patient population currently included.
Methods
The data sharing collaborative was started at the begin-
ning of the COVID-19 crisis in the Netherlands in March 
2020. All hospitals in the Netherlands with an intensive 
care unit were approached to participate. Per hospital, 
an intensivist and IT-professional served as contacts for 
local study approval, data expertise, and data extraction. 
All hospitals that participated have access to the cumula-
tive dataset for research purposes. The process of obtain-
ing legal approval and the extract–transform–load (ETL) 
pipeline, as well as the data mapping, data enrichment, 
and data validation process are described in detail. An 
overview of the project can be found in Fig. 1.
Legal and privacy
In close collaboration with data protection officers 
(DPO), health care lawyers, and intensivists, we drafted 
a data sharing agreement (DSA) and a multidisciplinary 
report on the lawful collection of EHR data during the 
COVID-19 crisis. Under the General Data Protection 
Regulation (GDPR) and Dutch law, data subjects are 
required to give explicit consent for the processing of 
their data. We argued, however, that during the COVID-
19 crisis asking consent could not be reasonably expected 
from health care workers due to (a) the large number 
of expected patients and associated time burden in an 
already overstrained health care system, (b) the danger 
Results: Out of the 81 intensive care units in the Netherlands, 66 participated in the collaboration, 47 have signed 
the data sharing agreement, and 35 have shared their data. Data from 25 hospitals have passed through the ETL and 
processing pipeline. Currently, 3464 patients are included in the DDW, both from wave 1 and wave 2 in the Nether‑
lands. More than 200 million clinical data points are available. Overall ICU mortality was 24.4%. Respiratory and hemo‑
dynamic parameters were most frequently measured throughout a patient’s stay. For each patient, all administered 
medication and their daily fluid balance were available. Missing data are reported for each descriptive.
Conclusions: In this study, we show that EHR data from critically ill COVID‑19 patients may be lawfully collected and 
can be combined into a data warehouse. These initiatives are indispensable to advance medical data science in the 
field of intensive care medicine.
Keywords: Database, Big data, COVID‑19, Data sharing
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of spreading or contracting the virus upon contact with 
patients or their families, and (c) the poor clinical condi-
tion of many patients in the intensive care. Consent was 
therefore not only impractical, but often infeasible. In 
addition, alternative forms of data collection to construct 
a database of this size were unavailable and selection bias 
would have ensued in case of failed consents.
As under non-crisis circumstances, COVID-19 data 
necessary for scientific purposes may be gathered when 
researchers “provide for suitable and specific measures to 
safeguard the fundamental rights and interests of the data 
subject” (GDPR, Article 9, paragraph j) [12]. Therefore, 
we (a) pseudonymized data in the providing hospital, (b) 
informed patients through media and local hospital out-
lets about the possibility to opt out, and (c) signed data 
sharing agreements regulating privacy of patients. The 
study proposal and documentation were reviewed and 
approved by the institutional review board of Amsterdam 
UMC location VUmc prior to study onset. Data sharing 
agreements were approved locally in each hospital before 
data transfers took place. The DSA has been added to the 
Additional files 1 and 2. All institutional review board 
documentation is available upon request from the corre-
sponding author.
Fig. 1 Overview of the Dutch Data Warehouse pipeline. Overview of the collaboration to realize the Dutch Data Warehouse. EHR electronic health 
record, ETL extract–transform–load
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Extract–transform–load pipeline
In collaboration with local IT-experts, template Struc-
tured Query Language (SQL) queries were written to 
automatically extract EHR data from each of the major 
EHR systems in the Netherlands: MetaVision (iMDsoft, 
Tel Aviv, Israel), HiX (ChipSoft, Amsterdam, The Neth-
erlands), and Epic (Epic Systems, Verona, WA, United 
States). Intensive care COVID-19 patients were labelled 
locally by the participating hospitals. All adult patients 
with laboratory-confirmed COVID-19 or a Reporting 
and Data System (CO-RADS) score with clinical sus-
picion compatible with the diagnosis were labeled for 
inclusion (13).
The extracted data included demographics, clini-
cal observations manually entered by the clinical team, 
administered medication, laboratory determinations, and 
data from vital sign monitors and life support devices 
such as mechanical ventilators, renal replacement devices 
and extracorporeal life support devices. Clinical notes, 
radiology reports and images, pathology and microbiol-
ogy data were not extracted due to the additional com-
plexity of these data and potential privacy implications. 
We included Dutch national registry data on patient 
comorbidities since these data are unsystematically 
recorded in the EHR and are frequently part of clinical 
notes [13].
IT experts from the participating hospitals adjusted 
the structured queries to local system configurations and 
performed the data extraction and pseudonymisation. 
Pseudonymisation was performed using a Secure Hash 
Algorithm (SHA-256). Data were stored in CSV format 
and shared with end-to-end encryption. Data extractions 
were performed upon request depending on the num-
ber of newly admitted patients. Upon receiving the data 
transfers, tables from the different EHR systems were 
restructured and data were combined into a staging data-
base. A first data validation step was performed checking 
tables for completeness of columns, missing data, head-
ers, and delimiters. This process was repeated per hos-
pital to ensure completeness of data. After the staging 
database, data went through the data processing pipeline 
to be mapped, enriched, further validated and restruc-
tured to facilitate research.
Data mapping
One of the major challenges in combining multicenter 
EHR data is to find corresponding parameters between 
hospitals. No mandated set of recorded parameters 
exists for ICUs in the Netherlands, nor is there a stand-
ardized nomenclature for parameters, which results in 
between-hospital differences on several levels. First, 
parameter names may differ between hospitals and may 
include abbreviations, generating a plethora of unique 
parameters. In addition, certain parameters may be 
recorded in one hospital, but not in another. For exam-
ple, not all hospitals record Richmond Agitation and 
Sedation Scales (RASS). Moreover, the level of param-
eter detail may differ between hospitals. One hospital 
may distinguish between alanine transferase (ALAT) 
measured in blood versus ALAT measured in other 
body fluids. Lastly, varying units between centers fur-
ther hampers finding corresponding parameters. These 
between-hospital differences greatly complicate the 
combination of multicenter EHR data.
Through a process called mapping, parameters from 
different hospitals are linked to a concept from a pre-
defined vocabulary. Although international vocabular-
ies such as Logical Observation Identifiers Names and 
Codes (LOINC) and Systematized Nomenclature of 
Medicine Clinical Terms (SNOMED CT) exist [14–16], 
no widespread mapping tooling is available and existing 
vocabularies may not yet be complete for the intensive 
care unit [17]. Considering the urgency of the COVID-
19 pandemic, we therefore created our own vocabulary 
of 942 clinically relevant parameters. We incorporated 
all 5.456 medications included in the Anatomical Ther-
apeutic Chemical (ATC) classifications from the World 
Health Organization Collaborating Center for Drugs 
Statistics Methodology [18]. Most, but not all hospi-
tals specified ATC codes for administered medication. 
Medications without an ATC code were mapped manu-
ally. Finally, we created a separate vocabulary of catego-
ries for 54 categorical concepts such as heart rhythm. 
These vocabularies included prespecified concepts for 
these categories, such as atrial fibrillation, ventricular 
tachycardia, and so on in the case of heart rhythm.
The received parameters were manually mapped per 
hospital to the predefined concept vocabulary. In order to 
facilitate the mapping process, the median, interquartile 
ranges, number of measurements, min, max, number and 
percentage of unique patients with the parameter, unit, 
and the most frequent value were calculated per parame-
ter and exported to Google sheets for the mapping. Con-
sequently, the concepts were aggregated into higher level 
concepts by the clinical team. For example, temperatures 
measured in the bladder and esophagus were both aggre-
gated into the higher-level temperature concept. Both the 
detailed as well as the aggregated mappings are available 
in the DDW. Next, units were checked for each param-
eter and adjusted where necessary. Lastly, all mappings 
were independently reviewed by an intensive care clini-
cian and discussed with the original hospital in case of 
uncertainty about the mapping. An overview of the most 
frequent concepts in the DDW can be found in Table 1.
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Table 1 Most frequent parameters in the Dutch Data Warehouse by number of observations
Obs number of observations, Pat number of patients with at least one observation, Hosp number of hospitals with at least one observation, FiO2 fraction of inspired 
O2, vent mode ventilation mode
Category Parameter name Parameter subname Obs Pat Hosp.
Respiratory fio2 fio2 unspecified 3,242,962 385 7
Respiratory fio2 fio2 set 6,143,804 2927 25
Respiratory fio2 fio2 optiflow 633 70 1
Respiratory fio2 fio2 hiflow 7223 266 5
Respiratory fio2 fio2 measured 2,095,235 1809 20
Respiratory fio2 fio2 niv 707 65 2
Respiratory Vent mode Vent mode 10,614,561 2970 25
Respiratory Vent mode Vent mode invasive 15,580 756 11
Respiratory Vent mode Vent mode machine 8755 396 4
Respiratory Vent mode Vent mode manual 644 105 5
Respiratory Vent mode Vent mode noninvasive 3630 315 6
Respiratory Peep Peep set 5,976,874 2389 24
Respiratory Peep Peep unspecified 20,479 116 2
Respiratory Peep Peep measured 3,786,729 2432 22
Hemodynamics Heart rate Heart rate ECG 827 179 3
Hemodynamics Heart rate Heart rate unspecified 7,095,759 2920 25
Hemodynamics Heart rate Heart rate monitor 836,776 740 5
Respiratory o2 saturation Saturation o2 peripheral monitor 1,677,619 654 4
Respiratory o2 saturation Saturation o2 peripheral 5,447,816 3086 23
Hemodynamics Arterial blood pressure mean Arterial bp mean 6,538,822 3284 24
Respiratory Lung compliance static Lung compliance static 1,281,683 317 6
Respiratory Lung compliance static Lung compliance static adjusted 4,739,724 2515 25
Hemodynamics Arterial blood pressure systolic Arterial bp systolic 5,901,827 3286 24
Hemodynamics Arterial blood pressure diastolic Arterial bp diastolic 5,896,330 3285 24
Respiratory Pressure above peep Pressure support set 240,321 23 1
Respiratory Pressure above peep Inspiratory pressure above peep 5,427,631 2429 24
Respiratory Driving pressure Driving pressure 4,851,963 2519 25
Respiratory Driving pressure Driving pressure adjusted 746,687 1662 22
Respiratory Tidal volume Tidal volume expiratory 3,694,052 2546 22
Respiratory Tidal volume Tidal volume expiratory measured 1,413,883 122 3
Respiratory Tidal volume Tidal volume expiratory unspecified 19,056 109 1
Respiratory Tidal volume Tidal volume measured 26,262 32 1
Respiratory Tidal volume Tidal volume set 409,944 1383 22
Respiratory Peak pressure Peak pressure measured 156,117 18 1
Respiratory Peak pressure Peak inspiratory pressure 5,364,952 2687 25
Respiratory Respiratory rate spontaneous Respiratory rate measured spontaneous 4,799,514 934 9
Respiratory Respiratory rate spontaneous Respiratory rate measured ventilator spontaneous 489,793 1270 13
Respiratory Tidal volume per kg Tidal volume per kg 5,240,012 2683 25
Respiratory Minute volume Minute volume unspecified 791,194 287 6
Respiratory Minute volume Minute volume set 9414 239 5
Respiratory Minute volume Minute volume expiratory 4,408,260 2488 22
Respiratory Respiratory rate measured ventilator Respiratory rate measured ventilator 5,010,244 2408 23
Respiratory Mean pressure Mean airway pressure 4,590,042 2291 22
Respiratory End tidal co2 End tidal co2 measured 4,193,165 2597 24
Respiratory Flow trigger set Flow trigger set 3,531,317 1247 20
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Data enrichment
Because several medical concepts are insufficiently stored 
in the EHR, we added derived concepts to the DDW 
based on clinical expertise. These concepts included the 
conversion of recorded concepts, the addition of novel 
clinical concepts, and the calculation of clinical scores. 
The conversion of concepts ensured that concepts were 
added to the database when they could be derived from 
other available concepts. For example, respiratory sys-
tem compliance can be calculated when tidal volume 
and driving pressure are available [19]. Secondly, clini-
cal concepts that have been described in the literature 
were added to the DDW and included ventilatory ratio 
[20], physiologic dead space [21], and mechanical power 
[22]. These derived concepts can be found in Table 2 and 
included specific algorithms per concept to ensure the 
correct selection of underlying parameters. Lastly, clini-
cal scores such as the Sequential Organ Failure Assess-
ment (SOFA) score [23] and the Acute Physiology and 
Chronic Health Evaluation II (APACHE II) score [24] 
were calculated from the data per calendar day for each 
patient and can be found in Additional file 3: Table S1.
In addition to the derived concepts, some concepts 
required more complex derivation algorithms. Nota-
bly, patient in- and extubation times may not be easily 
or reliably available in EHR data, or result from multi-
ple data columns. Therefore, we developed an algorithm 
that determines the start and end of intubation episodes 
based on other concepts. The overview of this algorithm 
has been published previously [11].
Data validation
Data validation and quality control were integrated 
throughout the project. The internal validity of the data 
was safeguarded by incorporating data that were vali-
dated by the clinical team during routine care, comparing 
calculated clinical scores against the manually recorded 
benchmarking scores from national registry data, and 
by data verification checks with the original hospital. In 
addition, several checkpoints ensured accurate process-
ing of the data throughout the ETL and data process-
ing pipeline. First, patient tables, headers, and column 
data were checked for completeness in the ETL pipe-
line. Secondly, parameter mappings were checked by 
an intensive care clinician and were therefore indepen-
dently performed by two clinicians. Next, value distri-
bution plots were continuously generated as part of the 
processing pipeline. These plots show the distribution 
of all parameters from all hospitals that were mapped 
to a certain concept and easily identify aberrant map-
pings. For all concepts, medically impossible cutoff val-
ues were determined by the clinical domain experts. 
Finally, demographics and any inconsistencies in the dis-
tributions or mapping were validated with their original 
hospital.
Data and code availability
The pipelines were constructed in Python 3 (Python 
Software Foundation). The resulting DDW is stored on 
a remote server. An application programming interface 
(API) was developed to facilitate data access. Access to 
the server is regulated to comply with the data sharing 
agreements. All hospitals have access to the data. Exter-
nal researchers can get access to all data in collabora-
tion with any of the participating hospitals. The list of 
collaborators is available in the co-author list and in 
the declarations section. The collaborators may be con-
tacted directly, through the corresponding author, or 
through the contact information on Amsterdammedi-
caldatascience.nl [25]. Research questions have to be in 
the line with the reason for data collection as outlined in 
the DSA; the investigation of the ICU course of COVID-
19 or its potential treatments. In addition, researchers 
have to sign a code of conduct before getting access to 
the data. Data access is granted by Amsterdam UMC; 
compliance with the DSA is the responsibility of the 
researcher and hospital accessing the data. A repository 
to process the data warehouse, including more informa-
tion on table structures and data content, is available on 
Gitlab. Anyone can get access to the repository by con-
tacting the corresponding author.
Results
The data sharing collaboration was initiated in March 
2020. Out of 81 hospitals with an intensive care unit in 
the Netherlands, 66 hospitals currently participate in the 
project (7 hospitals did not have the IT infrastructure or 
resources to carry out the data extraction, 1 hospital did 
not treat COVID-19 patients, and 7 did not want to par-
ticipate or did not respond), 47 have signed the data shar-
ing agreement and 35 have shared their data. The time to 
get approval and extract data ranged between less than 
1  month and 6  months between hospitals. So far, data 
from 25 hospitals have passed through the ETL and data 
processing pipelines and are currently included in the 
DDW. These hospitals amount to a total of 3463 patients, 
both from wave 1 and wave 2 in the Netherlands. From 
these patients, more than 200 million clinical data points 
are available.
Parameter mapping
The mapping process of the received parameters resulted 
in a large mapping structure between all hospitals and 
EHR systems. From the staging database, 67,236 parame-
ters (32,570 parameters from EPIC, 19,492 from Hix, and 
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Table 2 Derived parameters in the Dutch Data Warehouse
Overview of all derived parameters and their calculation in the data warehouse. The tolerance gives the hours that two measurements may be apart. In case multiple 
observations are found in that time window, the slash indicates the hierarchy. i.e., 1 h/8 h/1 h means observations are included 1 h before, otherwise 8 h before, or 
lastly 1 h after the other measurement
Parameter Calculation Tolerance Comments
Basophils percentage Basophils divided by leukocytes 1 h
Body mass index Height divided by weight squared / A measurement is added for each measurement of 
weight, using the latest available height for the 
patient
Driving pressure Plateau pressure minus peep 8 h/1 h
Driving pressure Tidal volume divided by lung compliance static 1 h
Eosinophils percentage Eosinophils divided by leukocytes 1 h
Glasgow coma scale total Glasgow coma scale eye plus Glasgow coma scale 
motor plus Glasgow coma scale verbal
1 h
Inspiratory expiratory ratio Inspiratory time divided by expiratory time 1 h
Lung compliance dynamic Tidal volume divided by (peak pressure minus 
peep)
1 h
Lung compliance static Tidal volume divided by (plateau pressure minus 
peep)
1 h/8 h/1 h
Lung compliance static Tidal volume divided by pressure above peep 1 h
Lymphocytes percentage Lymphocytes divided by leukocytes 1 h
Mechanical power per kg Mechanical power divided by ideal body weight / Ideal body weight is calculated from the patient’s 
gender and height
Mechanical power (0.098 × respiratory rate measured ventilator times 
tidal volume times (peak pressure minus (driving 
pressure × 0.5)) × 0.001
1 h
Mechanical power (0.098 × respiratory rate measured ventilator 
times tidal volume times (peak pressure plus 
peep) × 0.001
1 h
Minute volume derived (tidal volume times respiratory rate meas‑
ured) × 0.001
1 h
Monocytes percentage Monocytes divided by leukocytes 1 h
Neutrophils percentage Neutrophils divided by leukocytes 1 h
Pao2 over fio2 po2 arterial divided by fio2 8 h/1 h Measurements of ‘fio2’ within 8 h *before* ‘po2’ are 
given priority over those measured within 1 h 
afterwards
Pco2 minus end tidal co2 pco2 arterial minus end tidal co2 8 h Measurements of ‘end tidal co2’ within 1 h *before* 
`pco2` are given priority over those measured 
afterwards
Physiological dead space pco2 minus end tidal co2 minus pco2 arterial 8 h Measurements of ‘pco2 arterial’ within 8 h *before* 
‘pco2 minus end tidal co2’ are given priority over 
those measured within 8 h afterwards
Plateau pressure Driving pressure minus peep 8 h/1 h
Po2 unspecified over fio2 po2 unspecified divided by fio2 8 h/1 h Measurements of ‘fio2’ within 8 h *before* ‘po2’ are 
given priority over those measured within 1 h 
afterwards
Rapid shallow breathing index (Respiratory rate set divided by tidal vol‑
ume) × 1000
1 h
Respiratory rate difference Respiratory rate measured ventilator minus respira‑
tory rate set
1 h
Tidal volume per kg Tidal volume divided by ideal body weight / Ideal body weight is calculated from the patient’s 
gender and height
Ureum over creatinine Ureum minus creatinine 1 h
Ventilatory ratio (minute volume times pco2 arterial) divided by 
(ideal body weight × 100 × 37.5)
1 h Ideal body weight is calculated from the patient’s 
gender and height
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15,174 parameters from MetaVision) were mapped to the 
common vocabulary. Next, 14,656 text parameters were 
mapped to categorical concepts. Part of these mappings 
were aggregated into 289 higher level concept names. 
The final list of the most frequent concepts and their clin-
ical categories can be found in Table 1.
Data tables
Figure  2 gives an overview of the included data in the 
DDW. Table 1 lists the most frequent concepts found in 
the DDW with the number of total measurements, and 
the number of patients and number of hospitals with at 
least one measurement available for that concept. The 
data are available in separate tables and include a patients 
table with demographics and admission details; a single-
timestamp table with all observations and measurements 
recorded at a single point in time; a range measurements 
table that contains parameters with a start and an end 
timestamp such as urine output, fluid output, and body 
position; a medications table with start times, end times, 
and dosing information; a diagnosis table with ICD-10 
codes when available; a parameters table with the sum-
mary of all parameters currently included in the DDW; 
an intubations table with the start and end of invasive 
mechanical ventilation; a comorbidities table; and an out-
comes table.
Clinical characteristics of patients
Table  3 describes the COVID-19 patients currently 
included in the DDW. The first patient was admitted on 
February 20, 2020, while the last patient was admitted on 
March 2, 2021. The median age was 64.0 (IQR 56.0, 72.0), 
and the majority of patients were male with a median 
BMI of 27.3 (IQR 24.3, 30.7). Overall ICU mortality was 
24.4%.
Importantly, the DDW includes data throughout the 
ICU admission. The most common parameters were 
respiratory parameters, notably the fraction of inspired 
Fig. 2 Overview of the Dutch Data Warehouse content. Overview of the data domains in the Dutch Data Warehouse. Examples of data are given 
per domain. EHR electronic health record, BMI body mass index, GCS Glasgow Coma Scale, RASS Richmond agitation and sedation scale, CAM-ICU 
confusion assessment method for the ICU, PEEP positive end‑expiratory pressure, ECMO extracorporeal membrane oxygenation, IV intravenous
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oxygen, the ventilation mode, and the positive end expira-
tory pressure. These parameters are measured and stored 
directly by the mechanical ventilator. Similarly, hemody-
namic parameters that are automatically recorded and 
stored are most prevalent, including heart rate and blood 
pressure. Lastly, fluid balance and all administered medi-
cations are available for each patient. Missing data are 
reported in a separate column for each descriptive.
Discussion
In this study, we present the Dutch Data Warehouse, a 
large multicenter database with electronic health record 
data collected throughout the ICU admission of critically 
ill COVID-19 patients in the Netherlands. Currently, 
the DDW contains 3463 patients with over 200 million 
data points. The first stable version has been released 
and is available to researchers within ethical and legal 
boundaries.
The intensive care unit is a natural habitat for large 
data sharing collaboratives, as much data are collected 
through routine monitoring, life support devices, and by 
the clinical team. Although many publicly available sin-
gle-center datasets have advanced our understanding of 
electronic health record data [4–6], multicenter data are 
crucial to enhance generalizability of results and account 
for between-center differences. The most important 
aspects of multicenter EHR data sharing include the legal 
framework, between-hospital concept mapping, and 
data preparation. Despite the complexity and volume of 
parameters received, we describe the legal basis for col-
lecting these data under European privacy laws and show 
that these data can technically be combined into a data 
warehouse suitable for research.
The DDW has been used both as a research database 
and to create reports per hospital to compare local prac-
tices. The high granularity of the data, the wide variety 
of clinical parameters, and the availability of the data 
throughout the ICU stay make the database especially 
suitable for research. Clinical questions in a wide variety 
of areas relating to COVID-19 may be answered with the 
data, such as ventilation strategies, the timing and effects 
of proning, and the occurrence of superinfections. Apart 
from hard clinical endpoints such as mortality or length 
of stay, the DDW also allows for the investigation of 
intermediate clinical endpoints, such as line infections or 
improvements in P/F ratios. In addition to research, the 
dataset was used to create reports for hospitals to discuss 
and learn from treatment variation. These reports were 
created upon request and discussed confidentially with 
the participating hospitals.
For any medical data science project, and in par-
ticular projects throughout the COVID-19 pandemic, 
understanding and verifying the underlying data is cru-
cial to interpret results. Reports have expressed wor-
ries about the quality of research conducted throughout 
the pandemic [26, 27]. The call for accurate, timely and 
reliable research data is larger than ever before. Only 
then, research can be replicated and checked by the 
scientific community. Undoubtedly, there will be mis-
takes and missing data in the Dutch Data Warehouse. 
Despite rigorous data preparation and validation, we 
believe that transparency of data and data sharing is key 
to continuously and collaboratively improve the dataset. 
Importantly, knowledge of intensive care medicine is 
indispensable when reviewing and evaluating the data, 
and thus, the involvement of critical care clinicians is 
paramount. With this report, we hope to encourage clini-
cians and researchers to get involved in data sharing col-
laborations. Moreover, we aim for this work to have laid 
out a roadmap for multicenter data sharing. Lastly, we 
have initiated ICUdata as a follow-up project. In this col-
laboration, we aim to collect and combine data from all 
ICU patients from as many ICUs as possible in the Neth-
erlands. More information can be found on ICUdata.nl.
The DDW also comes with limitations. First of all, 
patient transfers could introduce bias since outcomes 
or prior admission data may not be available for these 
patients. However, whenever data were available from 
the receiving hospital, their admissions were connected 
Table 3 Overview of patients in the Dutch Data Warehouse
Patients admitted in the participating hospitals between March 2020 and March 
2021
Overview of characteristics of patients currently included in the Dutch Data 
Warehouse
IQR interquartile range, CRRT continuous renal replacement therapy
a Patients are transferred from the ICU to other hospitals. Referrals are transfers 
received from other hospitals
b Hospital mortality was not available for 5 hospitals because of different ICU 
and hospital EHRs
c Patients still admitted at the time of data extraction




Age, years (median, IQR) 64.0 (56.0, 72.0) 3459
Body Mass Index, kg/m2 (median, IQR) 27.3 (24.3, 30.7) 849
Gender male, (n, %) 2498 (72.3) 3457
Transfersa, (n, %) 367 (10.6) 3463
Referralsa, (n, %) 784 (26.5) 2963
ICU mortality, (n, %) 707 (24.4) 2900
ICU or hospital  mortalityb, (n, %) 853 (29.4) 2900
Still  admittedc, (n, %) 196 (5.7) 3463
ICU length of stay, days (median, IQR) 7.1 (2.2, 16.0) 3306
Intubated, (n, %) 2644 (75.6) 3496
Length of intubation, days (median, IQR) 7.7 (2.9, 14.3) 2644
CRRT, (n, %) 427 (12.2) 3496
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in the DDW. Moreover, transfers show similar patient 
characteristics compared to non-transfers upon admis-
sion. Therefore, we believe the bias in these data will 
be limited. Secondly, since ICUs were operating at 
full capacity at times, it cannot be excluded that some 
patients that would have been admitted pre-COVID-19 
are not currently in this dataset. Thirdly, like any EHR 
dataset, there will be missing data. We believe that trans-
parency is essential to gauge potential limitations in spe-
cific research questions. More importantly, we aspire 
transparency to lead to changes in clinical practice to 
improve EHR datasets. Comorbidity data, for exam-
ple, are frequently not structurally stored in EHRs. We 
included comorbidity data form Dutch national regis-
try data, which may not be available in other countries. 
We encourage the community to think about minimally 
required datasets to be recorded and standardization of 
EHR parameters. This way, the field of medical data sci-
ence can advance for the benefit of critically ill patients.
Conclusion
To the best of our knowledge, the Dutch Data Warehouse 
is the first dedicated multicenter and full-admission 
electronic health record database with highly granular 
clinical data from critically ill COVID-19 patients. We 
describe solutions for the legal aspects, ETL pipeline, 
data mapping, data enrichment, and data validation. Cur-
rently, 3463 patients are included in the DDW with over 
200 million data points from patient demographics, clini-
cal observations, administered medication, laboratory 
determinations, and vital sign monitors and life support 
devices. The resulting data warehouse is available to cli-
nicians and researchers within ethical and legal bounda-
ries. We expect this work will encourage clinicians and 
researchers to be involved in EHR data sharing collabora-
tions to advance the field of medical data science.
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